Clinical Trial Update: Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating interleukin-2 for patients with stage III or stage IV renal cell carcinoma after surgical removal of the tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Cancer Biotherapy Research Group | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN